// App-Quantinova.ai

1590 : CD133-expressing circulating tumor cells might predict poor prognosis in patients with head and neck cancer

Researchers

Presenter

  • Jason Chia-Hsun Hsieh

Principal Investigators

  • Harber Hung-Bo Shiao

  • Bill Yuan-Jhih Chao

  • Ming-Jung Lin

  • John Wen-Cheng Chang

  • Hung-Ming Wang

  • Tyler Min-Hsien Wu

Medical Centers

  • Chang Gung Memorial Hospital, Taipei, Taiwan

  • Department of Chemical and Materials Engineering, Chang Gung University, Taoyuan, Taiwan

  • Graduate Institute of Biochemical and Biomedical Engineering, Chang Gung University, Taoyuan, Taiwan

  • Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan

  • Division of Hematology/Oncology, Department of Internal Medicine, Linkou Chang Gung Memorial Hospital and Chang Gung University, Taoyuan, Taiwan

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved